Latest news
Xenetic partner receives Israeli approvals for lymphoma study - Stock TitanStock Titan · Fri, 07 Aug 2026 12:35:00 GMTTakeda (TAK) insider Nicola Greenway plans sale of 34,603 ADSs - Stock TitanStock Titan · Thu, 06 Aug 2026 21:17:47 GMTDenali Therapeutics (NASDAQ: DNLI) posts Q2 loss and launches AVLAYAH - Stock TitanStock Titan · Thu, 06 Aug 2026 20:09:23 GMTNovavax (Nasdaq: NVAX) Q2 revenue $57M, swings to $53M loss - Stock TitanStock Titan · Thu, 06 Aug 2026 12:03:50 GMTNovavax, Inc. (Nasdaq: NVAX) swings to Q2 loss on lower sales - Stock TitanStock Titan · Thu, 06 Aug 2026 11:50:54 GMTLigand Adds More Than 120 Royalty Assets in XOMA Acquisition - Stock TitanStock Titan · Thu, 06 Aug 2026 11:08:47 GMTTakeda (NYSE: TAK) gets FDA OK for ORZEYFUL narcolepsy therapy - Stock TitanStock Titan · Thu, 06 Aug 2026 10:05:55 GMTTakeda's new medicine targets orexin deficiency in narcolepsy type 1 - Stock TitanStock Titan · Wed, 05 Aug 2026 22:10:00 GMT